Skip to main content
Top
Published in: Skeletal Radiology 3/2020

01-03-2020 | Histiocytosis | Case Report

Unusual manifestations of diffuse-type tenosynovial giant cell tumor in two patients: importance of radiologic-pathologic correlation

Authors: Ayca Dundar, Jason R. Young, Doris E. Wenger, Carrie Y. Inwards, Stephen M. Broski

Published in: Skeletal Radiology | Issue 3/2020

Login to get access

Abstract

Diffuse-type tenosynovial giant cell tumor (TSGCT) is a rare, locally aggressive neoplasm. It most commonly occurs in the knee, followed by the hip, and has distinctive imaging features, including mass-like foci of low T2 signal intensity, “blooming” on gradient-echo MRI, and pronounced uptake on FDG PET/CT. Histologically, TSGCT demonstrates a neoplastic population of mononuclear cells admixed with hemosiderin-laden macrophages, foamy histiocytes, inflammatory cells, and osteoclast-like giant cells. In cases where diffuse-type TSGCT presents in an uncommon location or with atypical features, the imaging diagnosis may be challenging. Furthermore, because of its polymorphous appearance, it may be mistaken microscopically for other neoplastic and non-neoplastic histiocytic lesions. Herein, we present two cases of diffuse-type TSGCT presenting as large masses, and underscore the importance of radiologic-pathologic correlation for accurate diagnosis.
Literature
1.
go back to reference Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum. 2011;40(6):539–46.CrossRef Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum. 2011;40(6):539–46.CrossRef
2.
go back to reference Stevenson J, Jaiswal A, Gregory J, Mangham D, Cribb G, Cool P. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle. Bone Joint J. 2013;95(3):384–90.CrossRef Stevenson J, Jaiswal A, Gregory J, Mangham D, Cribb G, Cool P. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle. Bone Joint J. 2013;95(3):384–90.CrossRef
3.
go back to reference Jaffe HL. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941;31:731–65. Jaffe HL. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941;31:731–65.
4.
go back to reference Mastboom MJ, Hoek DM, Bovée JV, van de Sande MA, Szuhai K. Does CSF 1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? Histopathology. 2019;74(2):332–40.CrossRef Mastboom MJ, Hoek DM, Bovée JV, van de Sande MA, Szuhai K. Does CSF 1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? Histopathology. 2019;74(2):332–40.CrossRef
5.
go back to reference West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci. 2006;103(3):690–5.CrossRef West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci. 2006;103(3):690–5.CrossRef
6.
go back to reference Organization WH, Cancer IAfRo. WHO classification of tumours of soft tissue and bone. Tumours of soft tissue: introduction. Geneva: WHO; 2013. p. 281–95. Organization WH, Cancer IAfRo. WHO classification of tumours of soft tissue and bone. Tumours of soft tissue: introduction. Geneva: WHO; 2013. p. 281–95.
7.
go back to reference Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008;28(5):1493–518.CrossRef Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008;28(5):1493–518.CrossRef
8.
go back to reference Verspoor FG, van der Geest IC, Vegt E, Veth RP, van der Graaf WT, Schreuder HW. Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol. 2013;9(10):1515–31.CrossRef Verspoor FG, van der Geest IC, Vegt E, Veth RP, van der Graaf WT, Schreuder HW. Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol. 2013;9(10):1515–31.CrossRef
9.
go back to reference Cheng XG, You YH, Liu W, Zhao T, Qu H. MRI features of pigmented villonodular synovitis (PVNS). Clin Rheumatol. 2004;23(1):31–4.CrossRef Cheng XG, You YH, Liu W, Zhao T, Qu H. MRI features of pigmented villonodular synovitis (PVNS). Clin Rheumatol. 2004;23(1):31–4.CrossRef
10.
go back to reference Masih S, Antebi A. Imaging of pigmented villonodular synovitis. Semin Musculoskelet Radiol. 2003;7(3):205–16.CrossRef Masih S, Antebi A. Imaging of pigmented villonodular synovitis. Semin Musculoskelet Radiol. 2003;7(3):205–16.CrossRef
11.
go back to reference Kang GH, Chi JG, Choi IH. Pigmented villonodular synovitis in the sacral joint with extensive bone destruction in a child. Pediatr Pathol. 1992;12(5):725–30.CrossRef Kang GH, Chi JG, Choi IH. Pigmented villonodular synovitis in the sacral joint with extensive bone destruction in a child. Pediatr Pathol. 1992;12(5):725–30.CrossRef
12.
go back to reference Melamed A, Bauer CA, Johnson JH. Iliopsoas bursal extension of arthritic disease of the hip. Radiology. 1967;89(1):54–8.CrossRef Melamed A, Bauer CA, Johnson JH. Iliopsoas bursal extension of arthritic disease of the hip. Radiology. 1967;89(1):54–8.CrossRef
13.
go back to reference Emile J-F, Diamond EL, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, et al. Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood. 2014;124(19):3016–9.CrossRef Emile J-F, Diamond EL, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, et al. Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood. 2014;124(19):3016–9.CrossRef
14.
go back to reference Garner HW, Bestic JM. Benign synovial tumors and proliferative processes. Semin Musculoskelet Radiol. 2013;17(2):177–8.CrossRef Garner HW, Bestic JM. Benign synovial tumors and proliferative processes. Semin Musculoskelet Radiol. 2013;17(2):177–8.CrossRef
15.
go back to reference Frick MA, Wenger DE, Adkins M. MR imaging of synovial disorders of the knee: an update. Radiol Clin N Am. 2007;45(6):1017–31 vii.CrossRef Frick MA, Wenger DE, Adkins M. MR imaging of synovial disorders of the knee: an update. Radiol Clin N Am. 2007;45(6):1017–31 vii.CrossRef
16.
go back to reference Broski SM, Murdoch NM, Skinner JA, Wenger DE. Pigmented villonodular synovitis: potential pitfall on oncologic 18F-FDG PET/CT. Clin Nucl Med. 2016;41(1):e24–31.CrossRef Broski SM, Murdoch NM, Skinner JA, Wenger DE. Pigmented villonodular synovitis: potential pitfall on oncologic 18F-FDG PET/CT. Clin Nucl Med. 2016;41(1):e24–31.CrossRef
17.
go back to reference Eustace S, Goldberg R, Williamson D, Melhem E, Oladipo O, Yucel E, et al. MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol. 1997;52(8):589–94.CrossRef Eustace S, Goldberg R, Williamson D, Melhem E, Oladipo O, Yucel E, et al. MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol. 1997;52(8):589–94.CrossRef
18.
go back to reference Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker. J Nucl Med. 2018;59(5):774–9.CrossRef Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker. J Nucl Med. 2018;59(5):774–9.CrossRef
19.
go back to reference Haroche J, Cohen-Aubart F, Emile J-F, Maksud P, Drier A, Tolédano D, et al. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease. J Clin Oncol. 2014;33(5):411–8.CrossRef Haroche J, Cohen-Aubart F, Emile J-F, Maksud P, Drier A, Tolédano D, et al. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease. J Clin Oncol. 2014;33(5):411–8.CrossRef
20.
go back to reference Arnaud L, Malek Z, Archambaud F, Kas A, Toledano D, Drier A, et al. 18F-fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128–38.CrossRef Arnaud L, Malek Z, Archambaud F, Kas A, Toledano D, Drier A, et al. 18F-fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128–38.CrossRef
21.
go back to reference Sakamoto A, Matsuyama A, Hisaoka M, Matsuda S. Bone involvement mimicking an aggressive bone lesion in a diffuse-type tenosynovial giant cell tumor in the thoracic vertebral lamina: a case report. J Orthop Case Reports. 2018;8(3):14.PubMed Sakamoto A, Matsuyama A, Hisaoka M, Matsuda S. Bone involvement mimicking an aggressive bone lesion in a diffuse-type tenosynovial giant cell tumor in the thoracic vertebral lamina: a case report. J Orthop Case Reports. 2018;8(3):14.PubMed
22.
go back to reference Dion E, Graef C, Miquel A, Haroche J, Wechsler B, Amoura Z, et al. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology. 2006;238(2):632–9.CrossRef Dion E, Graef C, Miquel A, Haroche J, Wechsler B, Amoura Z, et al. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology. 2006;238(2):632–9.CrossRef
23.
go back to reference Antunes C, Graca B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging. 2014;5(4):473–82.CrossRef Antunes C, Graca B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging. 2014;5(4):473–82.CrossRef
24.
go back to reference Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483–92.CrossRef Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483–92.CrossRef
25.
go back to reference Geldyyev A, Koleganova N, Piecha G, Sueltmann H, Finis K, Ruschaupt M, et al. High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis. Cancer Lett. 2007;255(2):275–83.CrossRef Geldyyev A, Koleganova N, Piecha G, Sueltmann H, Finis K, Ruschaupt M, et al. High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis. Cancer Lett. 2007;255(2):275–83.CrossRef
26.
go back to reference Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117(10):2778–82.CrossRef Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117(10):2778–82.CrossRef
Metadata
Title
Unusual manifestations of diffuse-type tenosynovial giant cell tumor in two patients: importance of radiologic-pathologic correlation
Authors
Ayca Dundar
Jason R. Young
Doris E. Wenger
Carrie Y. Inwards
Stephen M. Broski
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 3/2020
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-019-03325-7

Other articles of this Issue 3/2020

Skeletal Radiology 3/2020 Go to the issue